<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:xhtml="http://www.w3.org/1999/xhtml">
  <url>
    <loc>https://www.adanguyenx.com/blog</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-06-22</lastmod>
  </url>
  <url>
    <loc>https://www.adanguyenx.com/blog/longevity-l2ntg</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2023-08-09</lastmod>
  </url>
  <url>
    <loc>https://www.adanguyenx.com/blog/partial-reprogramming</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2025-07-22</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574799744-GEIRKT6LQ1GEIT6QPHBB/PartialReprogramming.png</image:loc>
      <image:title>Blog - Partial reprogramming deep dive: the good, bad, and partially unresolved - Make it stand out</image:title>
      <image:caption>A map of reprogramming companies’ progress and approach</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574799687-QXHAW80LBKCEOF5097Y0/histone.jpeg</image:loc>
      <image:title>Blog - Partial reprogramming deep dive: the good, bad, and partially unresolved - Make it stand out</image:title>
      <image:caption>Histone and DNA. Image credit.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574799706-A9C0O05JUZ0HDVM1Y3HX/fibroblast+correlation.png</image:loc>
      <image:title>Blog - Partial reprogramming deep dive: the good, bad, and partially unresolved - Make it stand out</image:title>
      <image:caption>Dynamics of epigenetic age and fibroblast identity expression over a 49-day reprogramming time course. Image credit.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574799541-0G7HAUXVY3AQEOLEGTLS/Frame+1.png</image:loc>
      <image:title>Blog - Partial reprogramming deep dive: the good, bad, and partially unresolved - Make it stand out</image:title>
      <image:caption>How different terms used to describe partial reprogramming relate to each other</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574799559-MULYAV0G9Z5AZEX8KM7V/reprogrammable-mice.png</image:loc>
      <image:title>Blog - Partial reprogramming deep dive: the good, bad, and partially unresolved - Make it stand out</image:title>
      <image:caption>How reprogrammable mice are made. Image credit.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574799694-H2BZ7WLJV4RDVR3UYUAL/Roux+correlation.png</image:loc>
      <image:title>Blog - Partial reprogramming deep dive: the good, bad, and partially unresolved - Make it stand out</image:title>
      <image:caption>Left: pooled screening of OSKM combinations on mesenchymal stem cells. Right: adipogenic cells. NT means “not treated”. Image credit.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574799548-0P9921Z5KGW886UK6FVF/OSKM+system.png</image:loc>
      <image:title>Blog - Partial reprogramming deep dive: the good, bad, and partially unresolved - Make it stand out</image:title>
      <image:caption>The OSKM system</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574799731-B8LDTNN6X0SD824RVCCD/Gill+CpG.png</image:loc>
      <image:title>Blog - Partial reprogramming deep dive: the good, bad, and partially unresolved - Make it stand out</image:title>
      <image:caption>Partially reprogrammed fibroblasts dedifferentiate then reacquire their initial cellular identity in their methylomes. Image credit.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574799532-SYGASSWOZ1NCG601OZ3D/timeline.png</image:loc>
      <image:title>Blog - Partial reprogramming deep dive: the good, bad, and partially unresolved - Make it stand out</image:title>
      <image:caption>A history of partial reprogramming. See full list of papers here.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574799575-FOZ8QEONTN34R8DQNWK2/PCA.png</image:loc>
      <image:title>Blog - Partial reprogramming deep dive: the good, bad, and partially unresolved - Make it stand out</image:title>
      <image:caption>PCAs from Chondronasiou 2022 and Sarkar 2020</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574799713-5MFZ1DEJTA8VUJ5LGXVB/Roux+result.png</image:loc>
      <image:title>Blog - Partial reprogramming deep dive: the good, bad, and partially unresolved - Make it stand out</image:title>
      <image:caption>Partially reprogrammed mesenchymal stem cells are predicted to return to control cell identities in RNA velocity analysis. Image credit.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574799723-375FR3DMX6R8EVC5NFHB/Gill+protocol.png</image:loc>
      <image:title>Blog - Partial reprogramming deep dive: the good, bad, and partially unresolved - Make it stand out</image:title>
      <image:caption>OSKM induction protocol in Gill 2021</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574799738-FCGH7MH567RJT5GATRBR/gill+diff.png</image:loc>
      <image:title>Blog - Partial reprogramming deep dive: the good, bad, and partially unresolved - Make it stand out</image:title>
      <image:caption>Difference in epigenetic age between negative controls and treated cells. Chart made from data in Gill 2021.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574799758-8C5X24H965JAH0F626KN/turn+indications.png</image:loc>
      <image:title>Blog - Partial reprogramming deep dive: the good, bad, and partially unresolved - Make it stand out</image:title>
      <image:caption>Turn’s target indications. Image credit.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574799583-X0K3FW8FIVSR4AVENBSQ/distribution+of+effects.png</image:loc>
      <image:title>Blog - Partial reprogramming deep dive: the good, bad, and partially unresolved - Make it stand out</image:title>
      <image:caption>Distribution of partial reprogramming effects across different types of tissues. Y-axis denotes the number of studies.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574799749-ORKUMG2S53AR4O4VBPI8/shift+gene+clock.png</image:loc>
      <image:title>Blog - Partial reprogramming deep dive: the good, bad, and partially unresolved - Make it stand out</image:title>
      <image:caption>How Shift’s gene clock enables discovery of alternative OSKM factors. Image credit.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574799567-995LL4Q4MKJ3VGVCU0WO/lifespan.png</image:loc>
      <image:title>Blog - Partial reprogramming deep dive: the good, bad, and partially unresolved - Make it stand out</image:title>
      <image:caption>Kaplan-Meier curve. The gray curve is the control, and the blue and red curves are treated mice. Image credit.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.adanguyenx.com/blog/a-history-of-partial-reprogramming</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2025-07-22</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574799481-0NSDU2FMR934FWGSE4W0/Frame+10+%283%29.png</image:loc>
      <image:title>Blog - A history of partial reprogramming: a semi-comprehensive list of papers - Make it stand out</image:title>
      <image:caption>Whatever it is, the way you tell your story online can make all the difference.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.adanguyenx.com/blog/seeking-intensity</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2025-07-22</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574799779-J79AB9OGDDDOE3I9R5IK/https___bucketeer-e05bbc84-baa3-437e-9518-adb32be77984.s3.amazonaws.com_public_images_3049b7b5-4fe7-40e6-bbdd-702290ca7188_1456x903.jpeg</image:loc>
      <image:title>Blog - Seeking intensity - Make it stand out</image:title>
      <image:caption>(Credit: Wellness Wisdom)</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.adanguyenx.com/blog/on-not-overthinking</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2025-07-22</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574799519-VFV2UT5XZIISGPD2OP1V/https___bucketeer-e05bbc84-baa3-437e-9518-adb32be77984.s3.amazonaws.com_public_images_f067bbc7-ff72-4e85-8919-6e5db8e74acc_886x499.jpeg</image:loc>
      <image:title>Blog - On not overthinking - Make it stand out</image:title>
      <image:caption>Whatever it is, the way you tell your story online can make all the difference.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574799516-ZT1NJULXDF2RXGJJAEPU/EvunkwFXcAAotvp.jpeg</image:loc>
      <image:title>Blog - On not overthinking - Make it stand out</image:title>
      <image:caption>Whatever it is, the way you tell your story online can make all the difference.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.adanguyenx.com/blog/living-the-life-you-choose</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2025-07-22</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574799502-8T2HDAONJ3J894C8CQB4/https___bucketeer-e05bbc84-baa3-437e-9518-adb32be77984.s3.amazonaws.com_public_images_b497eb63-f86a-4f67-99fb-a61937467cf7_982x340.png</image:loc>
      <image:title>Blog - Living the life you choose - Make it stand out</image:title>
      <image:caption>Smoky Mountains, Meteor Crater, Grand Canyon</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574799499-YJBZ3YCC3UUCT6YDCRSP/https___bucketeer-e05bbc84-baa3-437e-9518-adb32be77984.s3.amazonaws.com_public_images_db1bb2e6-63e3-424d-988c-aefa9da8bca0_1683x385.png</image:loc>
      <image:title>Blog - Living the life you choose - Make it stand out</image:title>
      <image:caption>Changing views from the car, from East to West</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.adanguyenx.com/blog/dont-try-to-cure-cancer</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2025-07-22</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574799492-I7K9XLSGB6GSDUYM3420/Screen+Shot+2021-03-17+at+4.31.17+PM.png</image:loc>
      <image:title>Blog - Don't try to cure cancer</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.adanguyenx.com/blog/to-make-the-most-rational-decisions-use-your-gut</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2025-07-22</lastmod>
  </url>
  <url>
    <loc>https://www.adanguyenx.com/blog/category/Biotech</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.adanguyenx.com/blog/category/Blog</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.adanguyenx.com/writing</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-06-22</lastmod>
  </url>
  <url>
    <loc>https://www.adanguyenx.com/longevity/genomic-instability</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-06-22</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574795757-K3RZYUSJLU12ISTNX76S/Genome+instability.png</image:loc>
      <image:title>Genomic instability - Make it stand out</image:title>
      <image:caption>Figure 1: Therapeutic approaches for genome instability. Areas with yellow highlight indicate target(s) not explored by existing companies. Company logo is followed by description of their approach, stage of development, and disease(s) they target.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574795762-6LWJEDBKIPHQSGDZE963/DNA+repair.png</image:loc>
      <image:title>Genomic instability - Make it stand out</image:title>
      <image:caption>Figure 2. DNA repair pathways (source: Vijg 2021)</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.adanguyenx.com/longevity/pathological-cells</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-06-22</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574797828-3NQD80EYN4DZLZQL9N3W/Pathological.png</image:loc>
      <image:title>Pathological cells - Make it stand out</image:title>
      <image:caption>Figure 1: Therapeutic approaches for pathological cells. Areas with yellow highlight indicate target(s) not explored by existing companies. Company logo is followed by description of their approach, stage of development, and disease(s) they target.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.adanguyenx.com/longevity/dysbiosis</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-06-22</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574798658-MM9HNBUJMBQYJULOX3MM/Dysbiosis.png</image:loc>
      <image:title>Dysbiosis - Make it stand out</image:title>
      <image:caption>Figure 1: Therapeutic approaches for dysbiosis. Areas with yellow highlight indicate target(s) not explored by existing companies. Company logo is followed by description of their approach, stage of development, and disease(s) they target.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.adanguyenx.com/future</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-06-22</lastmod>
  </url>
  <url>
    <loc>https://www.adanguyenx.com/longevity/ecm</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-06-22</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574803149-KXXVMIVLRTLQ7YCOYY1H/ECM.png</image:loc>
      <image:title>ECM stiffness - Make it stand out</image:title>
      <image:caption>Figure 1: Therapeutic approaches for ECM stiffness. Areas with yellow highlight indicate target(s) not explored by existing companies. Company logo is followed by description of their approach, stage of development, and disease(s) they target.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.adanguyenx.com/partial-reprogramming-tables</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-06-22</lastmod>
  </url>
  <url>
    <loc>https://www.adanguyenx.com/start-here-1</loc>
    <changefreq>daily</changefreq>
    <priority>1.0</priority>
    <lastmod>2025-06-22</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574810819-36GW7QE9W6ASHW3J40DE/Headshot.png</image:loc>
      <image:title>Start here - Hi, I’m Ada.</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.adanguyenx.com/longevity/autophagy</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-06-22</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574811721-TDWPIIFJXEDEC2NETCZL/molce-41-1-65f1.jpeg</image:loc>
      <image:title>Disabled macroautophagy - Make it stand out</image:title>
      <image:caption>Figure 2. Autophagy process (source: Nakamura and Yoshimori 2018)</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574811718-24CTT3UGOK33332J2IIL/Disabled+macroautophagy.png</image:loc>
      <image:title>Disabled macroautophagy - Make it stand out</image:title>
      <image:caption>Figure 1: Therapeutic approaches for disabled macroautophagy. Areas with yellow highlight indicate target(s) not explored by existing companies. Company logo is followed by description of their approach, stage of development, and disease(s) they target.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.adanguyenx.com/longevity/altered-cellular-communication</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-06-22</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574812745-NPBJMNXC6DZXTOMLJQAK/Cell+comm.png</image:loc>
      <image:title>Altered cellular communication - Make it stand out</image:title>
      <image:caption>Figure 1: Therapeutic approaches for altered cellular communication. Company logo is followed by description of their approach, stage of development, and disease(s) they target.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574812749-9W5IY1F5PB8GZU33PNZF/parabiosis.png</image:loc>
      <image:title>Altered cellular communication - Make it stand out</image:title>
      <image:caption>Figure 2: good and bad circulating factors (Source: Rybtsova et al. 2020)</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.adanguyenx.com/longevity</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-06-22</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574813632-SD96XXFPFLSRP3MDTKQR/Discover.png</image:loc>
      <image:title>Longevity Biotech Landscape - Make it stand out</image:title>
      <image:caption>Figure 6. Overview of “Discover” companies. Company logo is followed by description of their approach, stage of development, and disease(s) they target.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574813628-VTX7WWC9ZJSAIRUFKNJO/Reprogram.png</image:loc>
      <image:title>Longevity Biotech Landscape - Make it stand out</image:title>
      <image:caption>Figure 5. Overview of “Reprogram” companies and their development stage</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574813625-WEIISJQ7WQR1LJZBIKJD/Replace.png</image:loc>
      <image:title>Longevity Biotech Landscape - Make it stand out</image:title>
      <image:caption>Figure 4. Overview of “Replace” companies</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574813614-KRKY1MUADGOLOHYPTKA7/Frame+23.png</image:loc>
      <image:title>Longevity Biotech Landscape - Make it stand out</image:title>
      <image:caption>Figure 1: Visual representation of the four main longevity biotech paradigms</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574813618-RTEYBL1CMYN0R9GZ9XDW/Everything.png</image:loc>
      <image:title>Longevity Biotech Landscape - Make it stand out</image:title>
      <image:caption>Figure 2. Market map of all longevity biotech companies</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6857a6cb0bc3e85ce9c0196d/1750574813621-6QJMKS7Z49J3B0D7O39Y/Reset+and+Repair.png</image:loc>
      <image:title>Longevity Biotech Landscape - Make it stand out</image:title>
      <image:caption>Figure 3. Overview of “Reset and Repair” companies. Areas with yellow highlight indicate target(s) not explored by existing companies. Click on image to open a larger version in new tab.</image:caption>
    </image:image>
  </url>
</urlset>

